Clinical Trial

Acceptability and Feasibility of Simultaneous Screening for Viral Hepatitis B, C and HIV Among Drug Users and Vulnerable Populations, in Non-conventional Structures "Outside the Walls" by Dual Screening Method RTDs and FibroScan®

Study acronym: SCANVIRE2
Recruiting
View on ClinicalTrials.gov →
Summary
The "Scanvir" concept aims to achieve barriers to HCV screening and treating of marginalized patients. The concept is applicable to other various populations and territories and should effectively improve HCV patient's health outcomes. The main objective of the SCANVIR project was to evaluate the feasibility, acceptability and reproducibility of a "test, treat and cure" strategy for PWIDs and vulnerable populations during dedicated days in addiction care centers.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-03-25.
Status change: Not Yet Recruiting → Recruiting 2025-08-13
Trial Details
NCT Number NCT06904820
Lead Sponsor University Hospital, Limoges
Conditions Viral Hepatitis
Enrollment 2,300 participants
Start Date 2025-06-05
Primary Completion 2035-06-05 (estimated)
Study Completion 2035-06-05 (estimated)
Updated on ClinicalTrials.gov 2025-08-14